摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Ethyl-5-hydroxybenzaldehyde | 532966-64-6

中文名称
——
中文别名
——
英文名称
3-Ethyl-5-hydroxybenzaldehyde
英文别名
——
3-Ethyl-5-hydroxybenzaldehyde化学式
CAS
532966-64-6
化学式
C9H10O2
mdl
——
分子量
150.17
InChiKey
SOSZJZOUVDHZLE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Triazolone derivatives
    申请人:Clark Richard
    公开号:US20080015199A1
    公开(公告)日:2008-01-17
    A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability. [wherein R 1a , R 1b , R 1c and R 1d each independently represent hydrogen, etc.; R 2 represents optionally substituted phenyl, etc.; R 3 represents optionally substituted C6-10 aryl, etc.; and Z 1 and Z 2 each independently represent hydrogen]
    以下一般式(1)表示的化合物,其盐或上述化合物的合物是一种新型化合物,可用于治疗和/或预防与血栓形成相关的疾病,并且具有适当的物理化学稳定性,更安全。 [其中R1a,R1b,R1c和R1d分别独立表示氢等;R2表示可选择取代的苯基等;R3表示可选择取代的C6-10芳基等;Z1和Z2分别独立表示氢]
  • TRIAZOLONE DERIVATIVES
    申请人:CLARK Richard
    公开号:US20100190783A1
    公开(公告)日:2010-07-29
    A Compound represented by the following general formula (1): wherein R 1a , R 1b , R 1c and R 1d each independently represent hydrogen, etc.; R 2 represents optionally substituted phenyl, etc.; R 3 represents optionally substituted C6-10 aryl, etc.; and Z 1 and Z 2 each independently represent hydrogen or salts thereof or hydrates of the foregoing.
    以下是通式(1)表示的化合物:其中R1a,R1b,R1c和R1d各自独立地表示氢等;R2表示可选取代的苯基等;R3表示可选取代的C6-10芳基等;Z1和Z2各自独立地表示氢或其盐或其合物。
  • TRIAZOLONE DERIVATIVE
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP2000465A1
    公开(公告)日:2008-12-10
    A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability. [wherein R1a, R1b, R1c and R1d each independently represent hydrogen, etc.; R2 represents optionally substituted phenyl, etc.; R3 represents optionally substituted C6-10 aryl, etc.; and Z1 and Z2 each independently represent hydrogen]
    由以下通式(1)代表的化合物、其盐类或前述化合物的合物是一种新型化合物,可用于治疗和/或预防与血栓形成有关的疾病,且具有较高的安全性和适当的理化稳定性。 [其中 R1a、R1b、R1c 和 R1d 各自独立地代表氢等;R2 代表任选取代的苯基等;R3 代表任选取代的 C6-10 芳基等;Z1 和 Z2 各自独立地代表氢]
  • Triazolone derivative
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP2194046A1
    公开(公告)日:2010-06-09
    A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability. [wherein R1a, R1b, R1c and R1d each independently represent hydrogen, etc.; R2 represents optionally substituted phenyl, etc.; R3 represents optionally substituted C6-10 aryl, etc.; and Z1 and Z2 each independently represent hydrogen]
    由以下通式(1)代表的化合物、其盐类或前述化合物的合物是一种新型化合物,可用于治疗和/或预防与血栓形成有关的疾病,且具有更高的安全性和适当的理化稳定性。 [其中 R1a、R1b、R1c 和 R1d 各自独立地代表氢等;R2 代表任选取代的苯基等;R3 代表任选取代的 C6-10 芳基等;Z1 和 Z2 各自独立地代表氢]
  • Compositions containing hydroxy aromatic aldehydes and their use in treatments
    申请人:——
    公开号:US20030157154A1
    公开(公告)日:2003-08-21
    Disclosed are pharmaceutical and cosmetic compositions containing hydroxy aromatic aldehyde compounds. The disclosed compositions are useful as topical therapeutics for treating inflammatory dermatologic conditions. The disclosed compositions are also useful in transdermal and other systemic dose forms for treating other inflammatory conditions in mammals.
    所公开的是含有羟基芳香醛化合物的药物和化妆品组合物。所公开的组合物可作为局部治疗剂用于治疗皮肤炎症。所公开的组合物还可以透皮或其他全身剂量形式用于治疗哺乳动物的其他炎症。
查看更多